MedKoo Cat#: 574413 | Name: SSR-146977 HCl
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

SSR-146977 HCl is an NK3 receptor antagonist that inhibits senktide-induced inositol monophosphate formation and intracellular calcium mobilization.

Chemical Structure

SSR-146977 HCl
CAS#264618-38-4

Theoretical Analysis

MedKoo Cat#: 574413

Name: SSR-146977 HCl

CAS#: 264618-38-4

Chemical Formula: C35H43Cl3N4O2

Exact Mass: 0.0000

Molecular Weight: 658.11

Elemental Analysis: C, 63.88; H, 6.59; Cl, 16.16; N, 8.51; O, 4.86

Price and Availability

Size Price Availability Quantity
10mg USD 550.00 2 Weeks
50mg USD 1,700.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
SSR-146977 hydrochloride, SSR-146977 HCl
IUPAC/Chemical Name
(R)-3-(1-(3-(1-benzoyl-3-(3,4-dichlorophenyl)piperidin-3-yl)propyl)-4-phenylpiperidin-4-yl)-1,1-dimethylurea hydrochloride
InChi Key
HYPKKQPFHSNZBY-GXUZKUJRSA-N
InChi Code
InChI=1S/C35H42Cl2N4O2.ClH/c1-39(2)33(43)38-35(28-13-7-4-8-14-28)19-23-40(24-20-35)21-9-17-34(29-15-16-30(36)31(37)25-29)18-10-22-41(26-34)32(42)27-11-5-3-6-12-27;/h3-8,11-16,25H,9-10,17-24,26H2,1-2H3,(H,38,43);1H/t34-;/m0./s1
SMILES Code
O=C(N(C)C)NC1(C4=CC=CC=C4)CCN(CCC[C@]3(CN(C(C5=CC=CC=C5)=O)CCC3)[C@]2=CC=C(Cl)C(Cl)=C2)CC1.Cl
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO and ethanol
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Biological target:
SSR-146977 HCl is an NK3 receptor antagonist (Ki values are 0.26 and 19.3 nM in CHO cells expressing the human NK3 and NK2 receptor, respectively). SSR-146977 HCl also inhibits senktide-induced inositol monophosphate formation and intracellular calcium mobilization (IC50 = 10 nM).
In vitro activity:
To be determined
In vivo activity:
SSR-146977 is a potent and selective antagonist of the tachykinin NK3 receptor. In guinea pigs, SSR-146977 inhibited bronchial hyperresponsiveness to acetylcholine, bronchial microvascular permeability hypersensitivity to histamine, and cough provoked by citric acid. In gerbils, SSR-146977 inhibited turning behavior and prevented the decrease of locomotor activity mediated by the stimulation of NK3 receptors. Reference: Can J Physiol Pharmacol. 2002 May;80(5):482-8. https://pubmed.ncbi.nlm.nih.gov/12056557/
Solvent mg/mL mM comments
Solubility
DMSO 65.8 100.00
Ethanol 65.8 100.00
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 658.11 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
1. Anderson W, Newson P, Skeri M, Janssen N, Milne S, Yip J, Jungnickel S, Lynch-Frame A, Chahl LA. Effect of subchronic administration of tachykinin antagonists on response of guinea-pigs to mild and severe stress. Regul Pept. 2011 Jun 7;168(1-3):59-68. doi: 10.1016/j.regpep.2011.03.006. Epub 2011 Apr 13. PMID: 21477621. 2. Emonds-Alt X, Proietto V, Steinberg R, Advenier C, Daoui S, Naline E, Gueudet C, Michaud JC, Oury-Donat F, Poncelet M, Vilain P, Le Fur G, Maffrand JP, Soubrié P, Pascal M. Biochemical and pharmacological activities of SSR 146977, a new potent nonpeptide tachykinin NK3 receptor antagonist. Can J Physiol Pharmacol. 2002 May;80(5):482-8. doi: 10.1139/y02-041. PMID: 12056557.
In vitro protocol:
To be determined
In vivo protocol:
1. Anderson W, Newson P, Skeri M, Janssen N, Milne S, Yip J, Jungnickel S, Lynch-Frame A, Chahl LA. Effect of subchronic administration of tachykinin antagonists on response of guinea-pigs to mild and severe stress. Regul Pept. 2011 Jun 7;168(1-3):59-68. doi: 10.1016/j.regpep.2011.03.006. Epub 2011 Apr 13. PMID: 21477621. 2. Emonds-Alt X, Proietto V, Steinberg R, Advenier C, Daoui S, Naline E, Gueudet C, Michaud JC, Oury-Donat F, Poncelet M, Vilain P, Le Fur G, Maffrand JP, Soubrié P, Pascal M. Biochemical and pharmacological activities of SSR 146977, a new potent nonpeptide tachykinin NK3 receptor antagonist. Can J Physiol Pharmacol. 2002 May;80(5):482-8. doi: 10.1139/y02-041. PMID: 12056557.
1: Emonds-Alt et al (2002) Biochemical and pharmacological activities of SSR 146977, a new potent nonpeptide tachykinin NK3 receptor antagonist. Can.J.Physiol.Pharmacol. 80 482 PMID: 12056557